跳至主要内容
临床试验/NCT03195946
NCT03195946已完成1 期

Interventional, Open-label, Multiple-dose Study to Investigate the Effects of Multiple Doses of Lu AF35700 on the Pharmacokinetics of Cytochrome P450 (CYP450) Substrates Dextromethorphan (CYP2D6), Caffeine (CYP1A2), Omeprazole (CYP2C19), and Midazolam (CYP3A4/5) in Healthy Young Adults

H. Lundbeck A/S1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2017年6月16日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
24
试验地点
1
主要终点
AUC(0-inf): Area under the plasma concentration-time curve from zero to infinity

研究概览

简要总结

This study will help determine which types of drugs that may interact with Lu AF35700

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Body weight at least 50 kg and Body Mass Index 19 - 30 kg/m2
  • Good general health ascertained by a detailed medical history, laboratory tests and physical examination

排除标准

  • Pregnant or lactating women
  • Other protocol defined inclusion and exclusion criteria may apply

研究组 & 干预措施

Lu AF35700 and Cocktail of CYP450 substrates

Experimental

Day 1 oral midazolam administration, Day 2 Cocktail of CYP450 substrates administration. Daily Lu AF35700 administration from Day 5 to Day 28 with co-administration on Day 27 with oral midazolam and Day 28 with CYP450 substrate cocktail

干预措施: Lu AF35700 (Drug)

Lu AF35700 and Cocktail of CYP450 substrates

Experimental

Day 1 oral midazolam administration, Day 2 Cocktail of CYP450 substrates administration. Daily Lu AF35700 administration from Day 5 to Day 28 with co-administration on Day 27 with oral midazolam and Day 28 with CYP450 substrate cocktail

干预措施: Midazolam (Drug)

Lu AF35700 and Cocktail of CYP450 substrates

Experimental

Day 1 oral midazolam administration, Day 2 Cocktail of CYP450 substrates administration. Daily Lu AF35700 administration from Day 5 to Day 28 with co-administration on Day 27 with oral midazolam and Day 28 with CYP450 substrate cocktail

干预措施: Cocktail of CYP450 substrates (Drug)

结局指标

主要结局

AUC(0-inf): Area under the plasma concentration-time curve from zero to infinity

时间窗: Up to 24 hours post dose on the following days: Day 1 and 27 for oral midazolam. Day 2 and 28 for cocktail components.

Area under the plasma concentration-time curve from zero to infinity for oral midazolam and metabolite and all drug cocktail components and their metabolites

Cmax: Maximum observed concentration

时间窗: Up to 24 hours post dose on the following days: Day 1 and 27 for oral midazolam. Day 2 and 28 for Cocktail components.

Maximum observed concentration of oral midazolam and all drug cocktail components and their metabolites

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验